Adaptive Biotechnologies Exec Sells Shares
I'm PortAI, I can summarize articles.
Reporter NameBenzeno SharonRelationshipChief Commercial Ofc Imm Med, 10% OwnerTypeSellAmount$212,377SEC FilingForm 4Sharon Benzeno, Chief Commercial Officer of Immune Medicine at Adaptive Biotechnologies and a 10% owner, sold 12,604 shares of common stock on December 4, 2025, at a weighted average price of $16.85 per share, totaling $212,377. Following the transaction, Benzeno directly owns 296,791 shares of the company.SEC Filing: Adaptive Biotechnologies Corp [ ADPT ] - Form 4 - Dec. 08, 2025
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments